{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:09:20Z","timestamp":1790194160784,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bulcan.2024.11.008","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:18:22Z","timestamp":1735629502000},"page":"122-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["MG149 suppresses anaplastic thyroid cancer progression by inhibition of lysine acetyltransferase KAT5-mediated c-Myc acetylation"],"prefix":"10.1016","volume":"112","author":[{"given":"Pan","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanming","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengwen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2024.11.008_bib0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.bulcan.2024.11.008_bib0225","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nrendo.2017.76","article-title":"Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies","volume":"13","author":"Molinaro","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.bulcan.2024.11.008_bib0230","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/gs.2019.10.18","article-title":"Novel treatments for anaplastic thyroid carcinoma","volume":"9","author":"Ferrari","year":"2020","journal-title":"Gland Surg"},{"issue":"9","key":"10.1016\/j.bulcan.2024.11.008_bib0235","first-page":"1397","article-title":"Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000\u20132019. JAMA Oncol","volume":"6","author":"Maniakas","year":"2020"},{"issue":"38","key":"10.1016\/j.bulcan.2024.11.008_bib0240","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1038\/onc.2014.453","article-title":"KATs in cancer: functions and therapies","volume":"34","author":"Farria","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbrc.2021.11.029","article-title":"Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5\/GPX4 axis","volume":"585","author":"Li","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.bulcan.2024.11.008_bib0250","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1111\/cas.13776","article-title":"Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5","volume":"109","author":"Lin","year":"2018","journal-title":"Cancer Sci"},{"issue":"16","key":"10.1016\/j.bulcan.2024.11.008_bib0255","doi-asserted-by":"crossref","first-page":"20372","DOI":"10.18632\/aging.203417","article-title":"circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5","volume":"13","author":"Ren","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.bulcan.2024.11.008_bib0260","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.18632\/aging.203975","article-title":"Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression","volume":"14","author":"Wang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0265","doi-asserted-by":"crossref","first-page":"118374","DOI":"10.1016\/j.lfs.2020.118374","article-title":"FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner","volume":"259","author":"Du","year":"2020","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/ERC-18-0193","article-title":"KAT5 promotes invasion and metastasis through C-MYC stabilization in ATC","volume":"26","author":"Wei","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2011.11.001","article-title":"6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site","volume":"47","author":"Ghizzoni","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0280","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pupt.2017.03.006","article-title":"A 6-alkylsalicylate histone acetyltransferase inhibitor inhibits histone acetylation and pro-inflammatory gene expression in murine precision-cut lung slices","volume":"44","author":"van den Bosch","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.bulcan.2024.11.008_bib0285","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.bbadis.2018.05.026","article-title":"Myocardin-related transcription factor A (MRTF-A) contributes to acute kidney injury by regulating macrophage ROS production","volume":"1864","author":"Liu","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"10.1016\/j.bulcan.2024.11.008_bib0290","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1089\/ars.2016.6822","article-title":"A cross talk between BRG1 and males absent on the first contributes to reactive oxygen species production in a mouse model of non-alcoholic steatohepatitis","volume":"30","author":"Liu","year":"2019","journal-title":"Antioxid Redox Signal"},{"issue":"24","key":"10.1016\/j.bulcan.2024.11.008_bib0295","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1161\/CIRCULATIONAHA.118.035377","article-title":"Megakaryocytic leukemia 1 bridges epigenetic activation of NADPH oxidase in macrophages to cardiac ischemia-reperfusion injury","volume":"138","author":"Yu","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.bulcan.2024.11.008_bib0300","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5483\/BMBRep.2022.55.10.037","article-title":"Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells","volume":"55","author":"Moon","year":"2022","journal-title":"BMB Rep"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0305","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fmicb.2018.00788","article-title":"Inhibition of Tip60 reduces lytic and latent gene expression of Kaposi's sarcoma-associated Herpes virus (KSHV) and proliferation of KSHV-infected tumor cells","volume":"9","author":"Simpson","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0310","doi-asserted-by":"crossref","first-page":"844477","DOI":"10.3389\/fonc.2022.844477","article-title":"The CK1\u03b4\/\u025b-Tip60 axis enhances Wnt\/\u03b2-catenin signaling regulating \u03b2-catenin acetylation in colon cancer","volume":"12","author":"Ning","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.bulcan.2024.11.008_bib0315","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.3390\/cancers12102986","article-title":"VRK1 phosphorylates Tip60\/KAT5 and is required for H4K16 acetylation in response to DNA damage","volume":"12","author":"Garc\u00eda-Gonz\u00e1lez","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0320","doi-asserted-by":"crossref","first-page":"125825","DOI":"10.1016\/j.chemosphere.2020.125825","article-title":"Histone acetyltransferase promotes fluoride toxicity in LS8 cells","volume":"247","author":"Deng","year":"2020","journal-title":"Chemosphere"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41392-021-00667-4","article-title":"MG149 inhibits histone acetyltransferase KAT8-mediated IL-33 acetylation to alleviate allergic airway inflammation and airway hyperresponsiveness","volume":"6","author":"Liu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"10.1016\/j.bulcan.2024.11.008_bib0330","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/bph.13836","article-title":"Dual cyclin-dependent kinase 4\/6 inhibition by PD-0332991 induces apoptosis and senescence in oesophageal squamous cell carcinoma cells","volume":"174","author":"Chen","year":"2017","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.11.008_bib0335","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/ERC-15-0555","article-title":"Treatment of advanced thyroid cancer with targeted therapies: ten years of experience","volume":"23","author":"Viola","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.bulcan.2024.11.008_bib0340","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1634\/theoncologist.2014-0182","article-title":"Novel approaches in anaplastic thyroid cancer therapy","volume":"19","author":"Hsu","year":"2014","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bulcan.2024.11.008_bib0345","first-page":"3068","article-title":"Long noncoding RNA UCA1 promotes anaplastic thyroid cancer cell proliferation via miR-135a-mediated c-myc activation","volume":"18","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0350","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/ijms21010237","article-title":"Targeting XPO1 and PAK4 in 8505C Anaplastic thyroid cancer cells: putative implications for overcoming lenvatinib therapy resistance","volume":"21","author":"Khan","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"7157","key":"10.1016\/j.bulcan.2024.11.008_bib0355","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/nature06055","article-title":"Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response","volume":"448","author":"Gorrini","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0360","doi-asserted-by":"crossref","first-page":"2014568","DOI":"10.1155\/2022\/2014568","article-title":"KAT5 Inhibitor NU9056 suppresses anaplastic thyroid carcinoma progression through c-Myc\/miR-202 pathway","volume":"2022","author":"Xu","year":"2022","journal-title":"Int J Endocrinol"},{"issue":"6","key":"10.1016\/j.bulcan.2024.11.008_bib0365","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2013.170","article-title":"Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer","volume":"1","author":"Suzuki","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0370","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/jc.2014-2803","article-title":"Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations","volume":"100","author":"Smith","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.bulcan.2024.11.008_bib0375","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","article-title":"Epithelial-mesenchymal transitions in development and pathologies","volume":"15","author":"Thiery","year":"2003","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"10.1016\/j.bulcan.2024.11.008_bib0380","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1476-5829.2011.00313.x","article-title":"Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype","volume":"11","author":"Cervantes-Arias","year":"2013","journal-title":"Vet Comp Oncol"},{"issue":"35","key":"10.1016\/j.bulcan.2024.11.008_bib0385","doi-asserted-by":"crossref","first-page":"57213","DOI":"10.18632\/oncotarget.11127","article-title":"Celecoxib and sulindac inhibit TGF-\u03b21-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1","volume":"7","author":"Cha","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"10.1016\/j.bulcan.2024.11.008_bib0390","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1074\/jbc.M114.635540","article-title":"Acetylation stimulates the epithelial sodium channel by reducing its ubiquitination and degradation","volume":"290","author":"Butler","year":"2015","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.bulcan.2024.11.008_bib0395","doi-asserted-by":"crossref","first-page":"e0136247","DOI":"10.1371\/journal.pone.0136247","article-title":"Identification of the acetylation and ubiquitin-modified proteome during the progression of skeletal muscle atrophy","volume":"10","author":"Ryder","year":"2015","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.bulcan.2024.11.008_bib0400","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1128\/MCB.24.24.10826-10834.2004","article-title":"The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5\/PCAF and TIP60","volume":"24","author":"Patel","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.bulcan.2024.11.008_bib0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin Cancer Biol"},{"issue":"15","key":"10.1016\/j.bulcan.2024.11.008_bib0410","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJMoa1403352","article-title":"Response and acquired resistance to everolimus in anaplastic thyroid cancer","volume":"371","author":"Wagle","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2024.11.008_bib0415","doi-asserted-by":"crossref","first-page":"967286","DOI":"10.1155\/2015\/967286","article-title":"Chemosensitivity of anaplastic thyroid cancer based on a histoculture drug response assay","volume":"2015","author":"Uruno","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"1","key":"10.1016\/j.bulcan.2024.11.008_bib0420","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00018-004-4329-z","article-title":"Cisplatin-induced genes as potential markers for thyroid cancer","volume":"62","author":"Lapouge","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"10.1016\/j.bulcan.2024.11.008_bib0425","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41419-021-04344-w","article-title":"Transcriptional inhibition by CDK7\/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma","volume":"12","author":"Zeng","year":"2021","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.bulcan.2024.11.008_bib0430","first-page":"821","article-title":"Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene","volume":"11","author":"Yuki","year":"2004","journal-title":"Oncol Rep"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124004661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124004661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T11:07:54Z","timestamp":1737544074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124004661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0007455124004661"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.11.008","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MG149 suppresses anaplastic thyroid cancer progression by inhibition of lysine acetyltransferase KAT5-mediated c-Myc acetylation","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}